To conduct a Phase II placebo-controlled proof of concept study of acamprosate in 48 youth with Fragile X Syndrome. Four-year grant 2012-2016.
To conduct a Phase II placebo-controlled proof of concept study of acamprosate in 48 youth with Fragile X Syndrome. Four-year grant 2012-2016.